PG soft slot demo djarum play robopragma slot pulsa slot deposit pulsa tanpa potongan slot online PG soft slot giga djarum play slot mahjong slot mahjong ways mahjong ways slot online slot nexus slot zeus slot gacor slot gacor 2024
Can Constitution Save Us from Drug Price Controls? - Pacific Research Institute

Can Constitution Save Us from Drug Price Controls?

Horizontal,Image,Of,A,Box,Of,Compounded,Prescription,Medications,Shipped

AstraZeneca made its case against Medicare’s prescription drug price-setting scheme before a federal judge in Delaware last week. It’s one of several drugmakers challenging the program on constitutional grounds, among them Johnson & Johnson, Merck and Bristol Myers Squibb.

Defenders of the price control plan have portrayed these cases as the machinations of money-grubbing pharmaceutical companies determined to put profit before patients. But that narrative is dead wrong.

Indeed, when a company is in the business of inventing life-saving medicines, profit and patient well-being go hand-in-hand. The real threat to patients comes from Medicare. By upending the system of incentives that drives medical science forward, Medicare’s prescription drug price controls will stifle innovation for years to come.

Click to read the full article in Newsmax.

Nothing contained in this blog is to be construed as necessarily reflecting the views of the Pacific Research Institute or as an attempt to thwart or aid the passage of any legislation.

Subscribe to our newsletter:

This field is for validation purposes and should be left unchanged.
Scroll to Top